Cargando…
P.841QTc changes in the management of SARS-CoV-2 infection in patents schizophrenia spectrum disorders
Autores principales: | Garip, B., Yirtimci, S., Hakan, K., Ayidaga, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670933/ http://dx.doi.org/10.1016/j.euroneuro.2020.09.607 |
Ejemplares similares
-
P841: MOLECULAR MECHANISMS OF RESISTANCE TO IMMUNOMODULATORS IN MULTIPLE MYELOMA: AN IN VITRO STUDY
por: Alves, Raquel, et al.
Publicado: (2023) -
SARS-CoV-2 and Patent Activity
por: Nikitina, I. B., et al.
Publicado: (2021) -
P841: EXTRACELLULAR VESICLE PROTEINS AS BIOMARKER OF OUTCOME IN MULTIPLE MYELOMA - A REAL-WORLD STUDY
por: Arnault Carneiro, E., et al.
Publicado: (2022) -
Schizophrenia spectrum disorders following past exposure to ionizing radiation and SARS CoV-2 infection
por: Loganovsky, K., et al.
Publicado: (2022) -
Phosphorylation of Tyrosine 841 Plays a Significant Role in JAK3 Activation
por: Sun, Shengjie, et al.
Publicado: (2023)